Highlighting its commitment to promote the safety and welfare of its employees, Teleperformance Philippines will be offering free Covid-19 vaccinations for their more than 47,000 employees in the country nationwide.
This is in line with the global initiative of Teleperformance to provide free access to vaccines for all its employees worldwide. As the nation awaits the ongoing government reviews to allow distribution of the vaccine, Teleperformance Philippines is currently collaborating with government agencies and employers in the country to quickly secure the supply of safe and effective FDA-approved vaccines for 100% of their employees.
Teleperformance, a leading global group in digitally integrated business services, recently announced its plans to reimburse the cost of Covid-19 vaccinations for its more than 330,000 employees worldwide, wherever the vaccine is not being provided free of charge by the country’s healthcare system. The plan will be deployed in accordance with the decisions of the local authorities concerned and in partnership with key private healthcare partners across Teleperformance’s footprint, which spans 80 countries.
Since the start of the Covid-19 crisis, Teleperformance has paid careful attention to protecting its employees, notably with a strong focus on health and hygiene standards in all its locations, millions of masks proactively secured and distributed to its staff, the assertive move to a Work-at-Home delivery model in conjunction with its clients, and enforcement of extra physical distance at its operational sites, over and above local country guidelines.
A Great Place to Work® certified company, Teleperformance Philippines likewise initiated efforts throughout the pandemic to promote the safety and well-being of their employees while helping businesses adjust to the new environment. Aside from stringent health and safety protocols on site, they also implemented the work-at-home (WAH) model for thousands of employees and launched Teleperformance Cloud Campus, a model that allows home-based interaction experts to work from anywhere in the world while remaining connected virtually to their Teleperformance team through one of the Cloud Campus hubs.
Today, by offering the vaccine as a free, optional staff benefit, Teleperformance aims not only to honor its commitment to protecting the health of its people, but also to help governments address the pandemic with agile, large-scope support of vaccination programs deployed at the corporate level.
Teleperformance Chairman and Chief Executive Officer Daniel Julien remarked,“Nothing is more important in fulfilling our mission than the safety and health of all our employees. Since the beginning of this grave crisis, we have done everything in our power to ensure business continuity for our clients and protect the health and safety of our employees, our partners, and jobs in the communities where the Group is present. Now, more than ever, we are focused on the same priorities. Based on strong relationships with healthcare partners and in compliance with government decisions and procurement agendas, we are well prepared across the world to assist in securing critical Covid-19 vaccinations for our employees. The reimbursement of vaccination costs for our staff is another critical step in this commitment to our employees. We will support every employee in the Group who wants the vaccine, especially in countries where the public or private insurance system doesn’t cover the cost. We are also proud to be actively contributing to the ongoing fight against the virus by boosting vaccinations worldwide.”
Teleperformance Chief Executive Officer for US, Canada, and Philippines Mike Lytle added, “From the beginning, the safety and well-being of our employees has been our priority. While the past year has definitely been a challenging one for the company and its many employees and partners, the announcement of the vaccine brings hope for everyone across the globe and we are committed to giving free access to this for all our employees. As we wait for the distribution of the vaccine, we continue to maintain a positive outlook for the industry and the country. We enjoin everyone in the ongoing fight against Covid-19 by continuing to follow the government’s lead and practice safety measures and protocols wherever they are.”
